We are Proud to be Recognized among the Top 25 Healthcare Investors in 2022

We are Proud to Double Down on Zeda, which closed its $52 million Series B

We are Delighted that our Portfolio Company, miRecule, Entered into a Strategic Collaboration with Sanofi with Potential Future Milestone Payments of nearly $400 Million

We are Happy to Lead PrinterPrezz's Series A Financing

PrinterPrezz Inc combines additive manufacturing and nanotechnology with a foundry ecosystem to develop medical devices from concept and design through FDA approval and volume production.

We are Happy to lead Genalyte, Inc.'s Series C Expansion Round with Verily (an Alphabet subsidy)

We are Happy to Lead Filtricine's Seed Funding Round

Filtricine, Inc. is developing a proprietary targeted medical food technology to help cancer patients manage their diseases.

We are Happy to Co-lead Surge Care’s Pre-seed Funding Round

Our Founding Partners', Dr. Rami El Assal & Dr. S. Thad Connelly, Book Series is Published!

We are happy to receive the print of two-volume book series on Early Detection and Treatment of Head and Neck Cancers.

Dr. Rami El Assal joins PrinterPrezz Inc’s Board of Directors

In leading the Series A round and investor diligence, we were excited by PrinterPrezz’s continued growth trajectory.

We are Happy to Participate Delfina's Seed Funding Round

Delfina Care uses a patient-centered and data-driven approach to empower moms and their caregivers to have healthier babies.

For the Third Consecutive Year, 2020 was the Year of Healthcare IPOs.

The best performing IPOs in 2020 were in the Healthcare industry with an average return of 96% and 8 out of the top 10 IPO best performers were Healthcare companies.

For the Second Consecutive Year, 2019 was the Year of Healthcare IPOs.

While there were few massive IPOs in the last year, mostly in the Consumer Services and Tech industries (e.g., Uber, Lyft, and Slack) at least 66 Healthcare companies went public in 2019, constituting about 41% of all IPOs in all industries